Passage Bio, Inc. (PASG)
NASDAQ: PASG · Real-Time Price · USD
0.600
0.00 (0.00%)
At close: Jan 17, 2025, 4:00 PM
0.610
+0.010 (1.67%)
After-hours: Jan 17, 2025, 4:59 PM EST
Passage Bio Market Cap
Passage Bio has a market cap or net worth of $37.06 million as of January 17, 2025. Its market cap has decreased by -23.19% in one year.
Market Cap
37.06M
Enterprise Value
-21.95M
1-Year Change
-23.19%
Ranking
Category
Stock Price
$0.60
Market Cap Chart
Since February 28, 2020, Passage Bio's market cap has decreased from $956.75M to $37.06M, a decrease of -96.13%. That is a compound annual growth rate of -48.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 17, 2025 | 37.06M | 5.80% |
| Dec 31, 2024 | 35.03M | -36.74% |
| Dec 29, 2023 | 55.37M | -26.45% |
| Dec 30, 2022 | 75.28M | -78.09% |
| Dec 31, 2021 | 343.58M | -70.49% |
| Dec 31, 2020 | 1.16B | 21.70% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 653.46B |
| UnitedHealth Group | 469.12B |
| Johnson & Johnson | 353.99B |
| Novo Nordisk | 352.70B |
| AbbVie | 303.17B |
| Merck & Co. | 247.70B |
| Thermo Fisher Scientific | 214.07B |
| Intuitive Surgical | 211.09B |